January 9, 2019
Omya develops fast-dissolving, chewable tablets
Omya has developed Omyasprint, an orally disintegrating tablet (ODT) based on the excipient Omyapharm and vitamin B 12.
Pharmaceuticals, Biotechnology and Life Sciences
Omya has developed Omyasprint, an orally disintegrating tablet (ODT) based on the excipient Omyapharm and vitamin B 12.
Omya, a producer of industrial minerals informed Monday about a price increase of 7 – 9% for its Calcium Carbonate products in the US and Canada, from the start of the next year.
Omya said Wednesday it will showcase its Omyapharm multifunctional excipient platform based on functionalized calcium carbonate, a highly structured mineral At CPhI in Frankfurt.